Each year, first-year Michigan medical students are prepped for one of the most difficult tasks they’ll face in their field: breaking bad news.

The novel platform for chemoimmunotherapy eliminated colon cancer in 85 percent of treated mice.

A large randomized trial finds Keytruda given with chemotherapy resulted in 20 percent improved survival at one year.

A decadelong effort to genomically characterize multiple cancers begets a huge archive: 33 cancer types, 11,000 tumors and 27 new papers that explain the findings.

Stress granules help the body’s cells protect their most important messenger, RNA — a process that could give clues to cancer and other di

A newly announced $150 million gift to the University of Michigan Rogel Cancer Center will help fill the gaps in federal funding and support high-risk, high-reward